You have no items in your cart.
Higher COVID-19 Risk Tied to 2 MS Therapies, Even With Vaccination
COVID-19 News, Multiple Sclerosis News Today
Fully vaccinated multiple sclerosis (MS) patients who are treated with Ocrevus (ocrelizumab) or Gilenya (fingolimod) have a significantly higher risk of COVID-19 infection than those given other immunosuppressive therapies, according ... Read more